Lymphoproliferative lung disorders

Seminars in Respiratory and Critical Care Medicine

Volumn 26, Issue 5, 2005, Pages 490-501

  Chilosi, Marco ^a   Zinzani, Pier Luigi ^b   Poletti, Venerino ^c  

^a UNIVERSITY OF VERONA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c MORGAGNI PIERANTONI HOSPITAL   (Italy)

Author keywords

Lymphoma; MALT; Primary pulmonary

Indexed keywords

ALKYLATING AGENT; ANTINEOPLASTIC AGENT; RITUXIMAB;

B CELL LYMPHOMA; CLINICAL FEATURE; COUGHING; DYSPNEA; FEVER; HEMOPTYSIS; HISTOPATHOLOGY; HODGKIN DISEASE; HUMAN; LUNG DISEASE; LYMPHADENOPATHY; LYMPHOMA; LYMPHOMATOID GRANULOMATOSIS; LYMPHOPROLIFERATIVE DISEASE; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; PAIN; PLEURA EFFUSION; PRIORITY JOURNAL; RARE DISEASE; RECURRENT INFECTION; REVIEW; T CELL LYMPHOMA; THORAX RADIOGRAPHY; TREATMENT INDICATION; WORLD HEALTH ORGANIZATION;

DIAGNOSIS, DIFFERENTIAL; DIAGNOSTIC IMAGING; HUMANS; LUNG DISEASES; LYMPHOPROLIFERATIVE DISORDERS; NEOPLASM STAGING;

EID: 27644491085     PISSN: 10693424     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-922032     Document Type: Review

References (98)

1. Freeman C, Berg JW, Cutler SJ. Occurrence and prognosis of extranodal lymphomas. Cancer 1972;29:252-260
2. Harris NL, Jaffe ES, Diebold J, et al. The World Health Organization classification of neoplastic diseases of the haematopoietic and lymphoid tissues: report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997. Histopathology 2000;36:69-86
3. Sutcliffe SB, Gospodarowicz MK. Clinical features and management of localized extranodal lymphomas. In: Keating A, Armitage J, Burnet A, Newland A, eds. Haematology Oncology. Vol 2. Cambridge: Cambridge University Press; 1992:189-223
4. Kurtin PJ, Myers JL, Adlakha H, et al. Pathologic and clinical features of primary pulmonary extranodal marginal zone B-cell lymphoma of MALT type. Am J Surg Pathol 2001;25:997-1008
5. Lister TA, Crowther D, Sutcliffe SB, et al. Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswold Meeting. J Clin Oncol 1989;7:1630-1636
6. Hansen LA, Prakash UBS, Colby TV. Pulmonary lymphoma in Sjögren's syndrome. Mayo Clin Proc 1989;64:920-931
7. Lim JK, Lacy MQ, Kurtin PJ, et al. Pulmonary marginal zone lymphoma of MALT type as a cause of localised pulmonary amyloidosis. J Clin Pathol 2001;54:642-646
8. Montalban C, Obeso G, Gallego A, et al. Peripheral T-cell lymphoma; a clinicopathological study of 41 cases and evaluation of the prognostic significance of the updated Kiel classification. Histopathology 1993;22:303-310
9. Cordier J, Chailleux E, Lauque D, et al. Primary pulmonary lymphomas: a clinical study of 70 cases in nonimmunocompromised patients. Chest 1993;103:201-208
10. Poletti V, Romagna M, Gasponi A, Baruzzi G, Allen KA, Bronchoalveolar lavage in the diagnosis of low-grade, MALT type, B-cell lymphoma in the lung. Monaldi Arch Chest Dis 1995;50;191-194
11. Zaer FS, Braylan RC, Zander DS, Iturraspe JA, Almasri NM. Multiparametric flow cytometry in the diagnosis and characterization of low-grade pulmonary mucosa-associated lymphoid tissue lymphomas. Mod Pathol 1998;11:525-532
12. Achille A, Scarpa A, Montresor M, et al. Routine application of polymerase chain reaction in the diagnosis of monoclonality of B-cell lymphoid proliferations. Diagn Mol Pathol 1995;4:14-24
13. van Dongen JJ, Langerak AW, Bruggemann M, et al. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia 2003;17:2257-2317
14. Treasure J, Lane A, Jones DB, Wright DH. CD43 expression in B cell lymphoma. J Clin Pathol 1992;45:1018-1022
15. Begueret H, Vergier B, Parrens M, et al. Primary lung small B-cell lymphoma versus lymphoid hyperplasia: evaluation of diagnostic criteria in 26 cases. Am J Surg Pathol 2002;26:76-81
16. Raderer M, Vorbrck F, Formanck M, et al. Importance of extensive staging in patients with mucosa associated lymphoid tissue (MALT)-type lymphoma. Br J Cancer 2000;83:454-457
17. Thieblemont C, Bastion Y, Berger F, et al. Mucosa-associated lymphoid tissue gastrointestinal and nongastrointestinal lymphoma behaviour: analysis of 108 patients. J Clin Oncol 1997;15:1624-1630
18. Zinzani PL, Magagnoli M, Galieni P, et al. Nongastrointestinal low-grade mucosa-associated lymphoid tissue lymphoma: analysis of 75 patients. J Clin Oncol 1999;17:1254-1258
19. Cavalli F, Isaacson PG, Gascoyne RD, Zucca E. MALT Lymphomas. Hematology (Am Soc Hematol Educ Program) 2001:241-258
20. Thieblemont C, Berger F, Dumontet C, et al. Mucosa-associated lymphoid tissue lymphoma is a disseminated disease in one third of 158 patients analyzed. Blood 2000;95:802-806
21. Yonezumi M, Suzuki R, Suzuki H, et al. Detection of AP12-MALT1 chimaeric gene in extranodal and nodal marginal zone B-cell lymphoma by reverse transcription polymerase chain reaction (PCR) and genomic long and accurate PCR analyses. Br J Haematol 2001;115:588-594
22. Addis BJ, Hyjek E, Isaacson PG. Primary pulmonary lymphoma: a reappraisal of its histogenesis and its relationship to pseudolymphoma and lymphoid interstitial pneumonia. Histopathology 1988;13:1-17
23. Isaacson PG, Du MQ. MALT lymphoma: from morphology to molecules. Nat Rev Cancer 2004;4:644-653
24. Wotherspoon AC, Doglioni C, Diss TC, et al. Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet 1993;342:575-577
25. Ambrosetti A, Zanotti R, Pattaro C, et al. Most cases of primary salivary mucosa-associated lymphoid tissue lymphoma are associated either with Sjögren syndrome or hepatitis C virus infection. Br J Haematol 2004;126:43-49
26. Garbe C, Stein H, Dienemann D, Orfanos CE. Borrelia burgdorferi- associated cutaneous B cell lymphoma: clinical and immunohistologic characterization of four cases. J Am Acad Dermatol 1991;24:584-590
27. Kurosu K, Yumoto N, Furukawa M, Kuriyama T, Mikata A. Low-grade pulmonary mucosa-associated lymphoid tissue lymphoma with or without intraclonal variation. Am J Respir Crit Care Med 1998;158(5 Pt 1):1613-1619
28. Reichenberger F, Wyser C, Gonon M, Cathomas G, Tamm M. Pulmonary mucosa-associated lymphoid tissue lymphoma in a patient with common variable immunodeficiency syndrome. Respiration 2001;68:109-112
29. Mhawech P, Krishnan B, Shahab I. Primary pulmonary mucosa-associated lymphoid tissue lymphoma with associated fungal ball in a patient with human immunodeficiency virus infection. Arch Pathol Lab Med 2000;124:1506-1509
30. Nicholson AG, Wotherspoon AC, Jones AL, Sheppard MN, Isaacson PG, Corrin B. Pulmonary B-cell non-Hodgkin's lymphoma associated with autoimmune disorders: a clinicopathological review of six cases. Eur Respir J 1996;9:2022-2025
31. Gaur S, Trayner E, Aish L, Weinstein R. Bronchus-associated lymphoid tissue lymphoma arising in a patient with bronchiectasis and chronic Mycobacterium avium infection. Am J Hematol 2004;77:22-25
32. Ott G, Katzenberger T, Greiner A, et al. The t(11;18) (q21;q21) chromosome translocation is a frequent and specific aberration in low-grade but not high-grade malignant non-Hodgkin's lymphomas of the mucosa-associated lymphoid tissue (MALT-) type. Cancer Res 1997;57:3944-3948
33. Auer IA, Gascoyne RD, Connors JM, et al. t(11;18)(q21;q21) is the most common translocation in MALT lymphomas. Ann Oncol 1997;8:979-985
34. Rosenwald A, Ott G, Stilgenbauer S, et al. Exclusive detection of the t(11;18)(q21;q21) in extranodal marginal zone B cell lymphomas (MZBL) of MALT type in contrast to other MZBL and extranodal large B cell lymphomas. Am J Pathol 1999;155:1817-1821
35. Ye H, Liu H, Attygalle A, et al. Variable frequencies of t(11;18)(q21;q21) in MALT lymphomas of different sites: significant association with CagA strains of H. pylori in gastric MALT lymphoma. Blood 2003;102:1012-1018
36. Okabe M, Inagaki H, Ohshima K, et al. API2-MALT1 fusion defines a distinctive clinicopathologic subtype in pulmonary extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue. Am J Pathol 2003;162:1113-1122
37. Dierlamm J, Baens M, Wlodarska I, et al. The apoptosis inhibitor gene API2 and a novel 18q gene, MLT, are recurrently rearranged in the t(11;18)(q21;q21)p6 associated with mucosa-associated lymphoid tissue lymphomas. Blood 1999;93:3601-3609
38. Akagi T, Motegi M, Tamura A, et al. A novel gene, MALT1 at 18q21, is involved in t(11;18) (q21;q21) found in low-grade B-cell lymphoma of mucosa-associated lymphoid tissue. Oncogene 1999;18:5785-5794
39. Lucas PC, Yonezumi M, Inohara N, et al. Bcl10 and MALT1, independent targets of chromosomal translocation in malt lymphoma, cooperate in a novel NF-kappa B signaling pathway. J Biol Chem 2001;276:19012-19019
40. Inagaki H, Okabe M, Seto M, Nakamura S, Ueda R, Eimoto T. API2-MALT1 fusion transcripts involved in mucosa-associated lymphoid tissue lymphoma: multiplex RT-PCR detection using formalin-fixed paraffin-embedded specimens. Am J Pathol 2001;158:699-706
41. Liu H, Hamoudi RA, Ye H, et al. t(11;18)(q21;q21) of mucosa-associated lymphoid tissue lymphoma results from illegitimate non-homologous end joining following double strand breaks. Br J Haematol 2004;125:318-329
42. Sugiyama T, Asaka M, Nakamura T, Nakamura S, Yonezumi S, Seto M. API2-MALT1 chimeric transcript is a predictive marker for the responsiveness of H. pylori eradication treatment in low-grade gastric MALT lymphoma. Gastroenterology 2001;120:1884-1885
43. Lazarevic V, Cemerikic-Martinovic V, Suvajdzic N, Subotic D, Colovic M. Diffuse primary plasmacytoma of the lung. Haematologia (Budap) 2001;31:161-165
44. Lim JK, Lacy MQ, Kurtin PJ, Kyle RA, Gertz MA. Pulmonary marginal zone lymphoma of MALT type as a cause of localised pulmonary amyloidosis. Clin Pathol 2001;54:642-646
45. Dacic S, Colby TV, Yousem SA. Nodular amyloidoma and primary pulmonary lymphoma with amyloid production: a differential diagnostic problem. Mod Pathol 2000;13:934-940
46. Fiche M, Caprons F, Berger F, et al. Primary pulmonary non-Hodgkin's lymphomas. Histopathology 1995;26:529-537
47. Li G, Hansmann ML, Zwingers T, Lennert K. Primary lymphomas of the lung: morphological, immunohistochemical and clinical features. Histopathology 1990;16:519-531
48. Nicholson AG, Wotherspoon AC, Diss TC, et al. Pulmonary B-cell non-Hodgkin's lymphomas: the value of immunohistochemistry and gene analysis in diagnosis. Histopathology 1995;26:395-403
49. Cadranel J, Naccache J, Wislez M, Mayaud C. Pulmonary malignancies in the immunocompromised patient. Respiration 1999;66:289-309
50. Ray P, Antoine M, Mary-Krause M, et al. AIDS-related primary pulmonary lymphoma. Am J Respir Crit Care Med 1998;158:1221-1229
51. Polish LB, Cohn DL, Ryder JW, Myers AM, O'Brien RF. Pulmonary non-Hodgkin's lymphoma in AIDS. Chest 1989;96:1321-1326
52. Bazot M, Cadranel J, Benayoun S, Tassart M, Bigot JM, Carette MF. Primary pulmonary AIDS-related lymphoma: radiographic and CT findings. Chest 1999;116:1282-1286
53. Guinee D Jr, Jaffe E, Kingma D, et al. Pulmonary lymphomatoid granulomatosis: evidence for a proliferation of Epstein-Barr virus infected B-lymphocytes with a prominent T-cell component and vasculitis. Am J Surg Pathol 1994;18:753-764
54. Bolaman Z, Kadikoylu G, Polatli M, Barutca S, Culhaci N, Senturk T. Migratory nodules in the lung: lymphomatoid granulomatosis. Leuk Lymphoma 2003;44:197-200
55. Jaffe ES, Wilson WH. Lymphomatoid granulomatosis: pathogenesis, pathology and clinical implications. Cancer Surv 1997;30:233-248
56. Liebow AA, Carrington CR, Friedman PJ. Lymphomatoid granulomatosis. Hum Pathol 1972;3:457-558
57. Lipford EH Jr, Margolick JB, Longo DL, Fauci AS, Jaffe ES. Angiocentric immunoproliferative lesions: a clinicopathologic spectrum of post-thymic T-cell proliferations. Blood 1988;72:1674-1681
58. Katzenstein AL, Carrington CB, Liebow AA. Lymphomatoid granulomatosis: a clinicopathologic study of 152 cases. Cancer 1979;43:360-373
59. Guinee DG Jr, Perkins SL, Travis WD, Holden JA, Tripp SR, Koss MN. Proliferation and cellular phenotype in lymphomatoid granulomatosis: implications of a higher proliferation index in B cells. Am J Surg Pathol 1998;22:1093-1100
60. Morice WG, Kurtin PJ, Myers JL. Expression of cytolytic lymphocyte-associated antigens in pulmonary lymphomatoid granulomatosis. Am J Clin Pathol 2002;118:391-398
61. Sordillo PP, Epremian B, Koziner B, Lacher M, Lieberman P. Lymphomatoid granulomatosis: an analysis of clinical and immunologic characteristics. Cancer 1982;49:2070-2076
62. Haque AK, Myers JL, Hudnall SD, et al. Pulmonary lymphomatoid granulomatosis in acquired immunodeficiency syndrome: lesions with Epstein-Barr virus infection. Mod Pathol 1998;11:347-356
63. Fassas A, Jagannath S, Desikan KR, et al. Lymphomatoid granulomatosis following autologous stem cell transplantation. Bone Marrow Transplant 1999;23:79-81
64. Sebire NJ, Haselden S, Malone M, Davies EG, Ramsay AD. Isolated EBV lymphoproliferative disease in a child with Wiskott-Aldrich syndrome manifesting as cutaneous lymphomatoid granulomatosis and responsive to anti-CD20 immunotherapy. J Clin Pathol 2003;56:555-557
65. Macon WR, Williams ME, Greer JP, et al. Natural killer-like T-cell lymphomas: aggressive lymphomas of T-large granular lymphocytes. Blood 1996;87:1474-1483
66. de Bruin PC, Jiwa M, Oudejans JJ, et al. Presence of Epstein-Barr virus in extranodal T-cell lymphomas: differences in relation to site. Blood 1994;83:1612-1618
67. Karakus S, Yalcin S, Guler N, Coplu L, Ayhan A. Angiocentric T-cell lymphoma of the lung mimicking metastatic carcinoma: case report. J Exp Clin Cancer Res 1998;17:371-373
68. Maejima S, Kitano K, Ichikawa S, et al. T-cell non-Hodgkin's lymphoma of the lung. Intern Med 1993;32:403-407
69. Beltran Beltran S, de Tomas Labat ME, Ferreras Fernandez P. Primary Ki-1 positive anaplastic large cell non-Hodgkin's lymphoma of the lung. A case study and review of the literature. An Med Interna 2001;18:587-590
70. Radin AI. Primary pulmonary Hodgkin's disease. Cancer 1990;65:550-563
71. Chetty R, Slavin JL, O'Leary JJ, Ansari NA, Gatter KC. Primary Hodgkin's disease of the lung. Pathology 1995;27:111-114
72. Catterall JR, McCabe RE, Brooks RG, Remington JS. Open lung biopsy in patients with Hodgkin's disease and pulmonary infiltrates. Am Rev Respir Dis 1989;139:1274-1279
73. Kiani B, Magro CM, Ross P. Endobronchial presentation of Hodgkin lymphoma: a review of the literature. Ann Thorac Surg 2003;76:967-972
74. Browne P, Petrosyan K, Hernandez A, Chan JA. The B-cell transcription factors BSAP, Oct-2, and BOB.1 and the pan-B-cell markers CD20, CD22, and CD79a are useful in the differential diagnosis of classic Hodgkin lymphoma. Am J Clin Pathol 2003;120:767-777
75. Chilosi M, Pizzolo G. Biopathologic features of Hodgkin's disease. Leuk Lymphoma 1995;16:385-395
76. Stein H, Marafioti T, Foss HD, et al. Down-regulation of BOB.1/OBF.1 and Oct2 in classical Hodgkin disease but not in lymphocyte predominant Hodgkin disease correlates with immunoglobulin transcription. Blood 2001;97:496-501
77. Costa MB, Siqueira SA, Saldiva PH, Rabe KF, Mauad T. Histologic patterns of lung infiltration of B-cell, T-cell, and Hodgkin lymphomas. Am J Clin Pathol 2004;121:718-726
78. Kilgore TL, Chasen MH. Endobronchial non-Hodgkin's lymphoma. Chest 1983;84:58-61
79. Ueda T, Hosoki N, Isobe K, et al. Diffuse pulmonary involvement by mycosis fungoides: high-resolution computed tomography and pathologic findings. J Thorac Imaging 2002;17:157-159
80. Wolfe JD, Trevor ED, Kjeldsberg CR. Pulmonary manifestations of mycosis fungoides. Cancer 1980;46:2648-2653
81. Rubin DL, Blank N. Rapid pulmonary dissemination in mycosis fungoides simulating pneumonia: a case report and review of the literature. Cancer 1985;56:649-651
82. Tanaka N, Matsumoto T, Miura G, et al. CT findings of leukemic pulmonary infiltration with pathologic correlation. Eur Radiol 2002;12:166-174 Epub 2001 Oct 09
83. Trisolini R, Lazzari Agli L, Poletti V. Bronchiolocentric pulmonary involvement due to chronic lymphocytic leukemia. Haematologica 2000;85:1097
84. Gomez-De La Fuente E, Ortiz PL, Vanaclocha F, Rodriguez-Peralto JL, Iglesias L. Aggressive granulomatous mycosis fungoides with clinical pulmonary and thyroid involvement. Br J Dermatol 2000;142:1026-1029
85. Kitching PA, Gibbs AR. Pulmonary involvement by mycosis fungoides: a case showing angiocentric lesions and granulomas. Pathol Res Pract 1993;189:594-596 discussion 597-600
86. Filly R, Bland N, Castellino RA. Radiographic distribution of intrathoracic disease in previously untreated patients with Hodgkin's disease and non-Hodgkin's lymphoma. Radiology 1976;120:277-281
87. Scarpa A, Borgato L, Chilosi M, et al. Evidence of c-myc gene abnormalities in mediastinal large B-cell lymphoma of young adult age. Blood 1991;78:780-788
88. Menestrina F, Chilosi M, Bonetti F, et al. Mediastinal large-cell lymphoma of B-type, with sclerosis: histopathological and immunohistochemical study of eight cases. Histopathology 1986;10:589-600
89. Zinzani PL, Martelli M, Bertini M, et al. International Extranodal Lymphoma Study Group. Induction chemotherapy strategies for primary mediastinal large B-cell lymphoma with sclerosis: a retrospective multinational study on 426 previously untreated patients. Haematologica 2002;87:1258-1264
90. Zinzani PL, Tani M, Gabriele A, et al. Extranodal marginal zone B-cell lymphoma of MALT-type of the lung: single-center experience with 12 patients. Leuk Lymphoma 2003;44:821-824
91. Zinzani PL, Magagnoli M, Ascani S, et al. Nongastrointestinal mucosa-associated lymphoid tissue (MALT) lymphomas: clinical and therapeutic features of 24 localized patients. Ann Oncol 1997;8:883-886
92. Zucca E, Conconi A, Pedrinis E, et al. International Extranodal Lymphoma Study Group. Nongastric marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue. Blood 2003;101:2489-2495
93. Wohrer S, Drach J, Hejna M, et al. Treatment of extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) with mitoxantrone, chlorambucil and prednisone (MCP). Ann Oncol 2003;14:1758-1761
94. Raderer M, Isaacson PG. Extranodal lymphoma of MALT-type: perspective at the beginning of the 21st century. Exp Rev Anticancer Ther 2001;1:53-64
95. Jager G, Neumeister P, Brezinschek R, et al. Treatment of extranodal marginal zone B-cell lymphoma of mucosa associated lymphoid tissue type with cladribine: a phase II study. J Clin Oncol 2002;20:3872-3877
96. Zinzani PL, Stefoni V, Musuraca G, et al. Fludarabine-containing chemotherapy as frontline treatment of non-gastrointestinal mucosa-associated lymphoid tissue lymphoma. Cancer 2004;100:2190-2194
97. Conconi A, Martinelli G, Thieblemont C, et al. Clinical activity of rituximab in extranodal marginal zone B-cell lymphoma of MALT type. Blood 2003;102:2741-2745
98. Thieblemont C, de la Fouchardiere A, Coiffier B. Nongastric mucosa-associated lymphoid tissue lymphomas. Clin Lymphoma 2003;3:212-224